X-FEL Coherent Diffraction Imaging Liposome Drug Distribution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current imaging techniques struggle to accurately determine the shape, size, and drug uptake of liposomes in a natural liquid environment, which is crucial for optimizing drug delivery, as they are anisotropic and non-uniform, and conventional methods like cryo-EM and SAXS are limited in such conditions.
Innovation Solution
The method employs X-FEL-based coherent diffraction imaging (CDI) to capture detailed structural information of individual liposomes and their contained drugs in water, using a specially designed sample holder and processing techniques like Guided Hybrid Input-Output (GHIO) and Shrink wrap algorithm to reconstruct images from diffraction patterns.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional imaging methods (cryo-EM, SAXS) are used to image liposomes, then structural information can be obtained, but the imaging cannot be performed in the natural liquid environment or on anisotropic non-uniform particles
Solution Approach 1:
The patent changes the imaging parameters by using X-FEL coherent diffraction imaging instead of conventional methods. This enables imaging of liposomes in their natural liquid environment and captures the anisotropic structures that were previously inaccessible to cryo-EM or SAXS techniques.
Solution Approach 2:
The patent replaces the mechanical freezing process of cryo-EM with X-ray free-electron laser coherent diffraction imaging. This substitution allows imaging in the natural liquid state without requiring freezing, thereby maintaining the physiological relevance of the liposome structures.
2Measurement precision
If standard imaging methods are used, then imaging process is simple, but they cannot detect drug rods inside liposomes or provide quantitative information on individual particles
Solution Approach 1:
The patent segments the imaging process into distinct stages: data collection using X-FEL, coherent diffraction pattern acquisition, and computational reconstruction using algorithms like GHIO and shrink-wrap. This segmentation enables detailed detection of drug rods inside liposomes while managing the complexity through systematic processing steps.
Solution Approach 2:
The patent introduces computational algorithms (GHIO, shrink-wrap) as intermediaries between the raw diffraction data and the final structural images. These algorithms process the coherent diffraction patterns to extract quantitative information about individual liposomes and their contained drug rods, bridging the gap between measurement and interpretation.
3Ease of manufacture
If liposomes are imaged in non-natural environments, then imaging is easier, but the structural information does not reflect the realistic drug delivery conditions
Solution Approach 1:
The patent changes the environmental parameter by maintaining liposomes in their natural liquid state during imaging rather than freezing or drying them. This preserves the physiological relevance of the structural information while using X-FEL CDI to overcome the previous technical limitations of liquid-state imaging.
Solution Approach 2:
The patent replaces the mechanical preservation methods (freezing for cryo-EM, drying for EM) with X-ray free-electron laser coherent diffraction imaging. This substitution allows direct imaging in the native liquid environment, ensuring that the structural information accurately reflects drug delivery conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides quantitative information on liposome structure and drug distribution, consistent with cryo-EM and SAXS data, enabling improved drug delivery optimization and compliance with certification requirements by imaging liposomes in their natural state.
Implementation Method 1
illuminating the aqueous sample with an X-ray free-electron laser (X-FEL); with an image sensor, collecting a plurality of coherent diffraction image patterns of the aqueous sample being illuminated
Data Source
AI summary
The present disclosure provides a method for imaging a compound contained by a lipid vesicle in water. The method comprises the following steps of: (a) providing an aqueous sample comprising the lipid vesicle which contains the compound, wherein the aqueous sample further comprises ammonium sulphate ((NH4)2SO4); (b) illuminating the aqueous sample with an X-ray free-electron laser (X-FEL); (c) with an image sensor, collecting a plurality of coherent diffraction image patterns of the aqueous sample being illuminated; and (d) reconstructing the coherent diffraction image patterns with a computer such that an image of the lipid vesicle containing the compound is acquired. A method for examining a quality of a chemical drug contained by a liposome in water is also provided.


